Bial - Articles and news items

EMA accepts submission for Zebinix use as a monotherapy for partial-onset seizures

EMA accepts submission for Zebinix use as a monotherapy for partial-onset seizures

Industry news / 17 May 2016 / Katie Sadler

The European Medicines Agency (EMA) has accepted Bial’s submission for once-daily epilepsy treatment Zebinix as monotherapy for partial-onset seizures.

Man dies after taking part in Phase I clinical trial

Industry news / 18 January 2016 / Victoria White

In a statement, The University Hospital of Rennes confirmed that five other participants in the clinical trial remain in a stable condition…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+